Synthesis and in Vitro Evaluation of Sulfonamide Isatin Michael Acceptors as Small Molecule Inhibitors of Caspase-6
Authors:
- 30 March 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (8) , 2188-2191
Abstract
A key step in the onset of Huntington’s disease is the caspase-6 mediated cleavage of the protein huntingtin into toxic fragments. Therefore, the inhibition of caspase-6 has been identified as a target for therapeutic drug development for the treatment of this disease. In this study, a series of isatin sulfonamide Michael acceptors having a high nanomolar potency for inhibiting caspase-6 and increased selectivity for caspase-6 versus caspase-3 inhibition is reported.Keywords
This publication has 31 references indexed in Scilit:
- Targets of Caspase-6 Activity in Human Neurons and Alzheimer DiseaseMolecular & Cellular Proteomics, 2008
- Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's DiseaseJournal of Neuroscience, 2004
- Active Caspase-6 and Caspase-6-Cleaved Tau in Neuropil Threads, Neuritic Plaques, and Neurofibrillary Tangles of Alzheimer's DiseaseThe American Journal of Pathology, 2004
- Role of caspases in neuronal apoptosisDrug Development Research, 2001
- Neuroprotection by the Inhibition of ApoptosisBrain Pathology, 2000
- Apoptosis and neurologic diseaseThe American Journal of Medicine, 2000
- Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer's DiseaseJournal of Biological Chemistry, 1999
- Mammalian Caspases: Structure, Activation, Substrates, and Functions During ApoptosisAnnual Review of Biochemistry, 1999
- Caspases: Enemies WithinScience, 1998
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997